Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

POLE-Mutant Colon Adenocarcinoma-Case Presentation and Histopathological Evaluation.

Journal of gastrointestinal cancer - 1 Jun 2024

Pancsa Tamás, Vasas Béla, Melegh Zsombor, Tóth Erika, Torday László, Sejben Anita

Abstract excerpt

INTRODUCTION: POLE mutant phenotype in colon adenocarcinomas represents a rare molecular subtype. These tumours are generally responsive to immune-checkpoint inhibition therapy and, therefore, are currently considered as a subtype with good prognosis. We hereby present the first detailed case presentation of a POLE mutant colon adenocarcinoma with useful microscopic features. CASE REPORT: A 53-year-old male...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Colonic Neoplasms
Share to DNA Polymerase II

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Microsatellite Instability

Share to Mutation

Share to Poly-ADP-Ribose Binding Proteins

Source

Identifiers

PMID: 38175383
DOI: 10.1007/s12029-023-01004-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

POLE-Mutant Colon Adenocarcinoma-Case Presentation and Histopathological Evaluation.PMID 38175383Read ↗

POLE-mutant colon adenocarcinoma – case presentation and histopathological evaluationSemantic proximity Read ↗

The clinical landscape of POLE-mutant colorectal cancer: a retrospective analysis of real-world outcome.Semantic proximity Read ↗

Morphological, immunophenotypical and molecular features of hypermutation in colorectal carcinomas with mutations in DNA polymerase ε ( POLE )Semantic proximity Read ↗

Rarity within rarity: complete response to chemoimmunotherapy in a patient with polymerase epsilon (POLE)-mutated locally advanced jejunal carcinoma.Semantic proximity Read ↗

High prevalence of unusual KRAS, NRAS, and BRAF mutations in POLE-hypermutated colorectal cancers.Semantic proximity Read ↗

PD-1 Blockade Elicits Ongoing Remission in Two Cases of Refractory Microsatellite-Stable Cancer Harboring a POLE Mutation.Semantic proximity Read ↗

Clinicopathologic Analysis of Five Patients with POLE-Mutated Colorectal Cancer in a Single Korean InstituteSemantic proximity Read ↗

Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study.Semantic proximity Read ↗

Distinct clinical pattern of colorectal cancer patients with POLE mutations: A retrospective study on real-world dataSemantic proximity Read ↗

Germline RAD54L with somatic POLE defect implicated in Hypermutation phenotype: case report.Semantic proximity Read ↗

Primary SMARCB1-deficient intestinal carcinoma: Clinicopathological and molecular characterization of three cases with analysis of published data.Semantic proximity Read ↗

Ultra-Hypermutation Driven by POLE Mutation in Metastatic Colorectal Cancer: A Case for Immunotherapy Without dMMRSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.